-
N-Rephasin® SAL200 Phase 1b Multiple Ascending Dose (MAD) Study Initia..
18 January,2018 -
Endolysin Based Treatment for Anthrax in Nature-Scientific Reports
17 January,2018 -
iNtRON’s Presentation at 2017 Antibiotics and Antibiotic Resistance Co..
08 December,2017 -
FDA Bacteriophage Workshop
08 December,2017 -
Shrimp EMS (Early Mortality Syndrome) and its solution
08 December,2017 -
iNtRON Biotechnology, TonaBACASE, the newly adopted name of SAL200 by ..
13 March,2017 -
Urgent Need for New Antibiotics Against Gram Negative Bacteria – “Post..
01 March,2017 -
N-Rephasin® SAL200 IRB(Institutional Review Board) Approval
03 January,2017
